Log In Sign up
The largest database of trusted experimental protocols

Bicalutamide

Manufactured by LKT Laboratories
Visit Supplier

Bicalutamide is a pharmaceutical compound used as a lab equipment product. It is an antiandrogen, which means it blocks the action of male hormones, such as testosterone. This compound is commonly used in research and laboratory settings to study its effects on biological systems.

Automatically generated - may contain errors

Lab products found in correlation

Rhodamine 123, by Merck Group (1 mentions) Cleaved parp, by Santa Cruz Biotechnology (1 mentions) Elacridar, by Merck Group (1 mentions) Ketoconazole, by LKT Laboratories (1 mentions) Casodex, by LKT Laboratories (1 mentions)

2 protocols using bicalutamide

1

Evaluating Docetaxel and Bicalutamide Sensitivity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Docetaxel (CAS#114977-28-5) was purchased from TSZ CHEM (Framingham, MA). Bicalutamide (Cat: #B3209) were purchased from LKT Laboratories, Int. Elacridar (Cat: #143664-11-3) and Rhodamine 123 (Cat: #62667-70-9) were purchased from Sigma-Aldrich. Anti-ser15 phosphorylated p53 antibody was obtained from Cell Signaling Technology, Int. Cleaved PARP, wt-p53 and tubulin antibodies were obtained from Santa Cruz Biotechnologies (Santa Cruz, CA).
Zhu Y., Liu C., Armstrong C., Lou W., Sandher A, & Gao A.C. (2015). Anti-androgens inhibit ABCB1 efflux and ATPase activity and reverse docetaxel resistance in advanced prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 21(18), 4133-4142.
+ Open protocol
+ Expand
2

Tasquinimod Metabolite Preparation

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
Ketoconazole and bicalutamide (i.e., casodex) were obtained from LKT Laboratories Inc. (St Paul, MN). Unlabeled tasquinimod and 14C-tasquinimod labeled in the 3 position of the quinoline nucleus at a specific activity of 33.9 mCi/mmol (> 90% purity) were provided by Active Biotech Inc. AB. Tasquinimod metabolites were prepared at Active Biotech AB (Lund, Sweden) as previously described [7 (link), 12 (link)].
Isaacs J.T., Dalrymple S.L., Rosen D.M., Hammers H., Olsson A, & Leanderson T. (2014). Anti-cancer potency of tasquinimod is enhanced via albumin-binding facilitating increased uptake in the tumor microenvironment. Oncotarget, 5(18), 8093-8106.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!